Abstract
Pleiotropic effects of serotonin (5-HT) in the cardiovascular system are well documented. However, it remains to be elucidated, whether 5-HT is present in adult mammalian cardiomyocytes. To address this issue, we investigated the levels of 5-HT in blood, plasma, platelets, cardiac tissue, and cardiomyocytes from adult mice and for comparison in human right atrial tissue. Immunohistochemically, 5-HT was hardly found in mouse cardiac tissue, but small amounts could be detected in renal preparations, whereas adrenal preparations revealed a strong positive immunoreaction for 5-HT. Using a sensitive HPLC detection system, 5-HT was also detectable in the mouse heart and human atrium. Furthermore, we could identify 5-HT in isolated cardiomyocytes from adult mice. These findings were supported by detection of the activity of 5-HT-forming enzymes—tryptophan hydroxylase and aromatic l-amino acid decarboxylase—in isolated cardiomyocytes from adult mice and by inhibition of these enzymes with p-chlorophenylalanine and 3-hydroxybenzyl hydrazine. Addition of the first intermediate of 5-HT generation, that is 5-hydroxytryptophan, enhanced the 5-HT level and inhibition of monoamine oxidase by tranylcypromine further increased the level of 5-HT. Our findings reveal the presence and synthesis of 5-HT in cardiomyocytes of the mammalian heart implying that 5-HT may play an autocrine and/or paracrine role in the heart.
Similar content being viewed by others
References
Verbeuren T (1990) The distribution and biochemistry of 5-HT in the cardiovascular system. Kluver Academic Press, Dordrecht, pp 3–13
Verbeuren T (1992) Distribution, synthesis, metabolism, release, uptake, and passage across body membranes in cardiovascular tissues including blood-brain barrier. Raven Press, New York, pp 29–39
Kaumann AJ (1994) Do human atrial 5-HT4 receptors mediate arrhythmias? Trends Pharmacol Sci 15:451–455
Robiolio PA, Rigolin VH, Wilson JS, Harrison JK, Sanders LL, Bashore TM, Feldman JM (1995) Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation 92:790–795
Kaumann AJ, Levy FO (2006) 5-hydroxytryptamine receptors in the human cardiovascular system. Pharmacol Ther 111:674–706
Yavarone MS, Shuey DL, Tamir H, Sadler TW, Lauder JM (1993) Serotonin and cardiac morphogenesis in the mouse embryo. Teratology 47:573–584
Nebigil CG, Choi DS, Dierich A, Hickel P, Le Meur M, Messaddeq N, Launay JM, Maroteaux L (2000) Serotonin 2B receptor is required for heart development. Proc Natl Acad Sci USA 97:9508–9513
Nebigil CG, Maroteaux L (2001) A novel role for serotonin in heart. Trends Cardiovasc Med 11:329–335
Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 46:157–203
Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533–554
Laer S, Remmers FO, Scholz H, Stein B, Muller FU, Neumann J (1998) Receptor mechanisms involved in the 5-HT-induced inotropic action in the rat isolated atrium. Br J Pharmacol 123:1182–1188
Tramontana M, Giuliani S, Del Bianco E, Lecci A, Maggi CA, Evangelista S, Geppetti P (1993) Effects of capsaicin and 5-HT3 antagonists on 5-hydroxytryptamine-evoked release of calcitonin gene-related peptide in the guinea-pig heart. Br J Pharmacol 108:431–435
Du XY, Schoemaker RG, Bos E, Saxena PR (1994) Different pharmacological responses of atrium and ventricle: studies with human cardiac tissue. Eur J Pharmacol 259:173–180
Gergs U, Neumann J, Simm A, Silber RE, Remmers FO, Laer S (2009) Phosphorylation of phospholamban and troponin I through 5-HT(4) receptors in the isolated human atrium. Naunyn Schmiedebergs Arch Pharmacol 379:349–359
Kaumann AJ, Sanders L, Brown AM, Murray KJ, Brown MJ (1990) A 5-hydroxytryptamine receptor in human atrium. Br J Pharmacol 100:879–885
Qvigstad E, Brattelid T, Sjaastad I, Andressen KW, Krobert KA, Birkeland JA, Sejersted OM, Kaumann AJ, Skomedal T, Osnes JB, Levy FO (2005) Appearance of a ventricular 5-HT4 receptor-mediated inotropic response to serotonin in heart failure. Cardiovasc Res 65:869–878
Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H, Bader M (2003) Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299:76
Popova NK (2006) From genes to aggressive behavior: the role of serotonergic system. BioEssays 28:495–503
Lee SL, Fanburg BL (1986) Serotonin uptake by bovine pulmonary artery endothelial cells in culture. I. Characterization. Am J Physiol 250:C761–C765
Mekontso-Dessap A, Brouri F, Pascal O, Lechat P, Hanoun N, Lanfumey L, Seif I, Benhaiem-Sigaux N, Kirsch M, Hamon M, Adnot S, Eddahibi S (2006) Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice. Circulation 113:81–89
Yusuf S, Al-Saady N, Camm AJ (2003) 5-hydroxytryptamine and atrial fibrillation: how significant is this piece in the puzzle? J Cardiovasc Electrophysiol 14:209–214
Ikeda K, Tojo K, Otsubo C, Udagawa T, Kumazawa K, Ishikawa M, Tokudome G, Hosoya T, Tajima N, Claycomb WC, Nakao K, Kawamura M (2005) 5-hydroxytryptamine synthesis in HL-1 cells and neonatal rat cardiocytes. Biochem Biophys Res Commun 328:522–525
Pönicke K, Gergs U, Hauptmann S, Buchwalow IB, Neumann J (2008) Release of 5-hydroxytryptamine from heart and isolated adult mice cardiomyocytes. Naunyn Schmiedebergs Arch Pharmacol 377(Suppl 1):57
Kirchhefer U, Neumann J, Baba HA, Begrow F, Reinke U, Schmitz W, Kobayashi YM, Jones LR (2001) Cardiac hypertrophy and impaired relaxation in transgenic mice overexpressing triadin 1. J Biol Chem 276:4142–4149
Buchwalow IB, Podzuweit T, Bocker W, Samoilova VE, Thomas S, Wellner M, Baba HA, Robenek H, Schnekenburger J, Lerch MM (2002) Vascular smooth muscle and nitric oxide synthase. FASEB J 16:500–508
Buchwalow IB, Podzuweit T, Samoilova VE, Wellner M, Haller H, Grote S, Aleth S, Boecker W, Schmitz W, Neumann J (2004) An in situ evidence for autocrine function of NO in the vasculature. Nitric Oxide 10:203–212
Lairez O, Calise D, Bianchi P, Ordener C, Spreux-Varoquaux O, Guilbeau-Frugier C, Escourrou G, Seif I, Roncalli J, Pizzinat N, Galinier M, Parini A, Mialet-Perez J (2009) Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload. J Mol Cell Cardiol 46:587–595
Izikki M, Hanoun N, Marcos E, Savale L, Barlier-Mur AM, Saurini F, Eddahibi S, Hamon M, Adnot S (2007) Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism: effects on hypoxic pulmonary hypertension in mice. Am J Physiol Lung Cell Mol Physiol 293:L1045–L1052
Kubovcakova L, Krizanova O, Kvetnansky R (2004) Identification of the aromatic l-amino acid decarboxylase gene expression in various mice tissues and its modulation by immobilization stress in stellate ganglia. Neuroscience 126:375–380
Lopez-Contreras AJ, Galindo JD, Lopez-Garcia C, Castells MT, Cremades A, Penafiel R (2008) Opposite sexual dimorphism of 3,4-dihydroxyphenylalanine decarboxylase in the kidney and small intestine of mice. J Endocrinol 196:615–624
Ni W, Watts SW (2006) 5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT). Clin Exp Pharmacol Physiol 33:575–583
Sole MJ, Shum A, Van Loon GR (1979) Serotonin metabolism in the normal and failing hamster heart. Circ Res 45:629–634
Cote F, Thevenot E, Fligny C, Fromes Y, Darmon M, Ripoche MA, Bayard E, Hanoun N, Saurini F, Lechat P, Dandolo L, Hamon M, Mallet J, Vodjdani G (2003) Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function. Proc Natl Acad Sci USA 100:13525–13530
Vaniotis G, Del Duca D, Trieu P, Rohlicek CV, Hébert TE, Allen BG (2011) Nuclear β-adrenergic receptors modulate gene expression in adult rat heart. Cell Signal 23:89–98
Kelly CJ, Johnson TC (1978) Effects of p-chlorophenylalanine and alpha-methylphenylalanine on amino acid uptake and protein synthesis in mouse neuroblastoma cells. Biochem J 174:931–938
Monassier L, Laplante MA, Ayadi T, Doly S, Maroteaux L (2010) Contribution of gene-modified mice and rats to our understanding of the cardiovascular pharmacology of serotonin. Pharmacol Ther 128:559–567
Gergs U, Baumann M, Böckler A, Buchwalow IB, Ebelt H, Fabritz L, Hauptmann S, Keller N, Kirchhof P, Klöckner U, Pönicke K, Rueckschloss U, Schmitz W, Werner F, Neumann J (2010) Cardiac overexpression of the human 5-HT4 receptor in mice. Am J Physiol Heart Circ Physiol 299:H788–H798
Ringvall M, Rönnberg E, Wernersson S, Duelli A, Henningsson F, Abrink M, García-Faroldi G, Fajardo I, Pejler G (2008) Serotonin and histamine storage in mast cell secretory granules is dependent on serglycin proteoglycan. J Allergy Clin Immunol 121:1020–1026
Correa-Araujo R, Oliveira JS, Ricciardi Cruz A (1991) Cardiac levels of norepinephrine, dopamine, serotonin and histamine in Chagas’ disease. Int J Cardiol 31:329–336
Mialet-Perez J, Bianchi P, Kunduzova O, Parini A (2007) New insights on receptor-dependent and monoamine oxidase-dependent effects of serotonin in the heart. J Neural Transm 114:823–827
Acknowledgments
The technical assistance of A. Spiess-Dunemann and I. Adler is greatly appreciated. This study was supported by the Deutsche Forschungsgemeinschaft (DFG).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pönicke, K., Gergs, U., Buchwalow, I.B. et al. On the presence of serotonin in mammalian cardiomyocytes. Mol Cell Biochem 365, 301–312 (2012). https://doi.org/10.1007/s11010-012-1270-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-012-1270-6